Carnegie Mellon University
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 13, 2025), Carnegie Mellon University reported 5 stock positions worth $131.6 million. Its top holding was Duolingo (DUOL) at 72.1% of the portfolio, followed by Invesco QQQ Trust Series 1 (QQQ, 27.9%) and Innsuites Hospitality Trust (IHT, 0.0%). Compared with Q2 2025, it reduced 1. The biggest sale was Predictive Oncology (shares −93%).
- Most Recent 13F
- Q2 2026
- Location
- Pittsburgh, PA
- CIK
- 0001039067
- Portfolio Value
- $131.6M (Q3 2025)
- SEC Filing
- 0000898432-25-000892 ↗ filed Nov 13, 2025
Holdings Value
Holdings 5 stocks · $131.6M
| DUOL Duolingo | 72.12% | 294,814 | $94.9M | No change |
| QQQ Invesco QQQ Trust Series 1 | 27.85% | 61,039 | $36.6M | No change |
| IHT Innsuites Hospitality Trust | 0.01% | 10,000 | $18K | No change |
| PREDICTIVE ONCOLOGY INC | 0.01% | 691 | $10K | Reduce -93.3% |
| LONGEVITY HEALTH HLDGS INC | 0.00% | 4,482 | $3K | No change |
Portfolio Sells Q2 2025 → Q3 2025
| PREDICTIVE ONCOLOGY INC | Reduce -93.3% | 0.01% | +0.00 |
Portfolio Buys Q2 2025 → Q3 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $78.9M | QQQ, DUOL, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q1 2026 | 5 | $64.3M | QQQ, DUOL, IHT, LONGEVITY HEALTH HLDGS INC, AGPU |
| Q4 2025 | 5 | $89.3M | DUOL, QQQ, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q3 2025 | 5 | $131.6M | DUOL, QQQ, IHT, PREDICTIVE ONCOLOGY INC, LONGEVITY HEALTH HLDGS INC |
| Q2 2025 | 5 | $154.6M | DUOL, QQQ, IHT, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC |
| Q1 2025 | 6 | $129.0M | DUOL, QQQ, PDD, IHT, LONGEVITY HEALTH HLDGS INC |
| Q4 2024 | 6 | $136.7M | DUOL, QQQ, PDD, LONGEVITY HEALTH HLDGS INC, IHT |
| Q3 2024 | 4 | $96.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q2 2024 | 4 | $73.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q1 2024 | 6 | $80.1M | DUOL, VERA, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC, NBSE |